DOSIMETRIC PARAMETERS PREDICTIVE OF TREATMENTRELATED TOXICITY IN HIGH DOSE-RATE BRACHYTHERAPY AS MONOTHERAPY FOR PROSTATE CANCER

被引：0
|
作者：
Song, Jiheon [1 ]
Corkum, Mark [1 ]
Loblaw, Andrew [1 ]
Chung, Hans [1 ]
Tseng, Chia-Lin [1 ]
Cheung, Patrick [1 ]
Szumacher, Ewa [1 ]
Liu, Stanley [1 ]
Chu, William [1 ]
Davidson, Melanie [1 ]
Wronski, Matt [1 ]
Zhang, Liying [1 ]
Mamedov, Alexandre [1 ]
Morton, Gerard [1 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2023年 / 186卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
44
引用
收藏
页码：S22 / S23
页数：2
相关论文
共 50 条
  • [1] Dosimetric Parameters Predictive of Treatment-Related Toxicity in High Dose-Rate Brachytherapy as Monotherapy for Prostate Cancer
    Song, J.
    Corkum, M. T.
    Loblaw, D. A.
    Chung, H. T.
    Tseng, C. L.
    Cheung, E.
    Szumacher, E.
    Liu, S. K.
    Chu, W.
    Davidson, M. T. M.
    Wronski, M.
    Zhang, L.
    Mamedov, A.
    Morton, G.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E438 - E439
  • [2] Single dose high dose-rate (HDR) brachytherapy as monotherapy for localised prostate cancer
    Tharmalingam, H.
    Tsang, Y. M.
    Hoskin, P.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S337 - S337
  • [3] HIGH DOSE-RATE BRACHYTHERAPY AS MONOTHERAPY FOR PROSTATE CANCER: ONE FRACTION MAY NOT BE ENOUGH
    Morton, Gerard
    McGuffin, Merrylee
    Chung, Hans
    Tseng, Eric
    Mendez, Lucas
    Hasan, Yaser
    Ravi, Ananth
    Zhang, Liying
    Loblaw, Andrew
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 139 : S39 - S39
  • [4] High dose-rate brachytherapy in the treatment of prostate cancer
    Mendez, Lucas C.
    Morton, Gerard C.
    [J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2018, 7 (03) : 357 - 370
  • [5] DOSIMETRIC PREDICTORS OF TOXICITY AND QUALITY OF LIFE FOLLOWING SINGLE FRACTION HIGH DOSE-RATE PROSTATE BRACHYTHERAPY
    Corkum, Mark T.
    Loblaw, Andrew
    Chung, Hans T.
    Tseng, Chia-Lin
    McGuffin, Merrylee
    Davidson, Melanie
    Paudel, Moti
    Wronski, Matt
    Cheung, Patrick
    Chu, William
    Szumacher, Ewa
    Zhang, Liying
    Mamedov, Alexandre
    Morton, Gerard
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 163 : S7 - S7
  • [6] Dosimetric Predictors of Toxicity and Quality of Life Following Single Fraction High Dose-Rate Prostate Brachytherapy
    Corkum, M. T.
    Loblaw, D. A.
    Chung, H. T.
    Tseng, C. L.
    McGuffin, M.
    Davidson, M. T. M.
    Paudel, M.
    Wronski, M.
    Cheung, P.
    Chu, W.
    Szumacher, E.
    Zhang, L.
    Mamedov, A.
    Morton, G.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E269 - E270
  • [7] THE DOSIMETRIC SIGNIFICANCE OF CATHETER DISPLACEMENT IN PROSTATE HIGH DOSE-RATE (HDR) BRACHYTHERAPY
    Soliman, H.
    Sankreacha, R.
    Hunt, D.
    Loblaw, A.
    Morton, G.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S32 - S32
  • [8] Efficacy/toxicity after high dose rate brachytherapy as monotherapy for localized prostate cancer
    Novikov, S.
    Kanaev, S.
    Gotovchikova, M.
    Novikov, R.
    Ilin, D.
    Girshovitch, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S586 - S587
  • [9] High Dose-Rate Prostate Brachytherapy as Monotherapy: a Single Fraction May Not be Enough
    Morton, G.
    McGuffin, M.
    Chung, H. T.
    Ravi, A.
    Tseng, C. L.
    Hasan, Y.
    Mendez, L. C.
    Loblaw, D. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S56 - S57
  • [10] A dosimetric comparison of high dose rate (HDR) and low dose-rate (LDR) prostate brachytherapy.
    Al-Hebshi, A
    Morton, G
    Sankreacha, R
    [J]. RADIOTHERAPY AND ONCOLOGY, 2004, 72 : S36 - S36
12345